참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 2-Fluorobenzylamine | HCID 66649 | — |
| 반응물 | 4-chloro-N-phenylpyridin-2-amine | HCID 23458041 | — |
| 시약 | Sodium t-butoxide | HCID 23676156 | — |
| 촉매 | Palladium (II) acetate | HCID 4144353 | — |
| 촉매 | (R)-(-)-1-[(S)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-t-butylphosphine;Ferrocene, 1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)-, (2R)- | HCID 144543273 | — |
| 용매 | Dimethylacetamide | HCID 31374 | — |
| 생성물 | 4-N-[(2-fluorophenyl)methyl]-2-N-phenylpyridine-2,4-diamine | HCID 101883694 | 62.09% |
반응 단계
(2-fluorophenyl)methanamine (67.3 mg, 0.54 mmol), 4-chloro-N- phenylpyridin-2-amine (100 mg, 0.49 mmol) and sodium 2-methylpropan-2-olate (94 mg, 0.98 mmol) were suspended in DMA (2 mL) and sealed into a microwave tube. Nitrogen was bubbled through the reaction mixture for 5 minutes. (R)-(-)-1-[(S)-2-(DICYCLOHEXYLPHOSPHINO)FERROCENYL]ETHYLDI-T-BUTYLPHOSPHINE (32.5 mg, 0.06 mmol) and diacetoxypalladium (8.78 mg, 0.04 mmol) were added to the reaction mixture and nitrogen was bubbled through the reaction mixture for a further 5 minutes. The reaction was heated thermally to 100 °C for 30 mins under nitrogen and cooled to RT. The reaction mixture was neutralised with HCl and purified by ion exchange chromatography, using a 20 g SCX column. The crude product was purified by flash silica chromatography, elution gradient 0 to 10% MeOH in DCM. Fractions containing product were evaporated to dryness to afford N4-(2-fluorobenzyl)-N2-phenylpyridine-2,4-diamine (89 mg, 62.1 %) as a white solid.
출처 및 근거
| 출처 데이터셋 | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-dfbe9b6e6d2042eaacda8fae236486c2 |
|---|
| 출처 메모 | 750 AstraZeneca ELN dataset |
|---|